益佰制药：预计2025年归母净利润亏损34200万元至28500万元

Core Viewpoint - Yibai Pharmaceutical announced an expected net loss for the fiscal year 2025, projecting a loss between 342 million to 285 million yuan for the net profit attributable to the parent company [2] Financial Performance - The company anticipates a net profit attributable to the parent company, excluding non-recurring gains and losses, to be between -336 million to -280 million yuan [2]